A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

Clinical trial NCT06521567 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06521567
Sponsor: GlaxoSmithKline
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma Hodgkin Lymphoma High and Low Grade Glioma Glioblastoma Multiforme (GBM)Diffuse Intrinsic Pontine Glioma (DIPG)Ependymoma Osteosarcoma Hepatic Tumors Hepatoblastoma Hepatocellular Carcinoma (HCC)Fibrolamellar Carcinoma Rhabdomyosarcoma

Start date: 2025-03-06
Primary completion: 2026-10-13
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.